Super Easymulti For Women
Natural health product licensed in Canada
- Licence holder
- Platinum Naturals Ltd.
- NPN or DIN-HM
- 80010715
- Status
- Inactive licence
- Licence date
- 8 June 2009
- Revision date
- 23 June 2010
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Contains tea (Camellia sinensis). Green tea extracts must provide less than 800 mg of epigallocatechin-3-gallate per daily portion, with mandatory warnings.
annexe III, partie B (règlement (UE) 2022/2340). Regulation (EC) No 1925/2006, latest consolidated version, retrieved 21 October 2026.
- Conditions légales
Camellia sinensis (L.) Kuntze: Seules sont admises la poudre issue du broyage des feuilles et les préparations obtenues à partir des solvants suivants : l'eau, l'alcool à 25 % (v/v), ainsi que les solvants autorisés pour la décaféination ou la suppression des matières irritantes et amères. Les recommandations d'emploi ne doivent pas conduire à une ingestion quotidienne d'EGCG supérieure à 300 mg. L'étiquetage doit comporter des avertissements déconseillant leur prise en dehors des repas, ainsi que leur consommation par les enfants, les adolescents, les femmes enceintes ou allaitantes.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Ginkgo biloba L.: L'étiquetage des compléments alimentaires qui contiennent la feuille de la plante Ginkgo biloba L. doit comporter un avertissement avec la teneur suivante: "Consultez votre médecin en cas de prise simultanée d'anticoagulants."
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Borago officinalis L.: Les préparations de cette plante sont autorisées s'il peut être démontré qu'elles ne dépassent pas 1 ppb d'alcaloïdes pyrrolizidiniques.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Magnésium Source : Oxyde de magnésium | 12.5 mg | Not calculated |
| Camellia sinensis Source : Feuille(s) Potency : 80 % Polyphenols | 12.5 mg | Not calculated |
| Crataegus laevigata Source : Fruit (berry) | 25 mg | Not calculated |
| Ascophyllum nodosum Source : Plante(s) entière | 25 mg | Not calculated |
| Chrome Source : Produit de chélation de chrome et de PVH | 100 mcg | Not calculated |
| Oenothera biennis Source : Huile de graines | 225 mg | Not calculated |
| Vitamine A Source : Palmitate de vitamine A Potency : 1,250 UI | 378 mcg EAR | Not calculated |
| Thiamine Source : Chlorhydrate de thiamine | 25 mg | Not calculated |
| Ginkgo biloba Source : Feuille(s) Potency : 24 % Flavonol glycosides | 40 mg | Not calculated |
| Ginkgo biloba Source : Feuille(s) Potency : 6 % Terpene lactones | Not specified | Not calculated |
| Vitamine A Source : Bêta carotène Potency : 2,500 UI | 375 mcg EAR | Not calculated |
| Coenzyme Q10 Source : Coenzyme Q10 | 12.5 mg | Not calculated |
| Vitamine D Source : Cholécalciférol Potency : 300 UI | 7.5 mcg | Not calculated |
| Borago officinalis Source : Huile de graines Potency : 22 % Gamma linolenic acid | 25 mg | Not calculated |
| Silybum marianum Source : Graine(s) Potency : 65 % Silymarin | 50 mg | Not calculated |
| Cuivre Source : Citrate cuivrique | 0.5 mg | Not calculated |
| Choline Source : Bitartrate de choline | 7.5 mg | Not calculated |
| Acide pantothénique Source : d-panthothénate de calcium | 25 mg | Not calculated |
| Biotine Source : Biotine | 150 mcg | Not calculated |
| Potassium Source : Citrate de potassium | 7.5 mg | Not calculated |
| Vitamine E Source : d-alpha-tocophérol Potency : 100 UI | 67 mg AT | Not calculated |
Non-medicinal ingredients
huile d'olive, lécithine de soja, Caramel, Gélatine, Glycérine, Persil, Eau purifiée, Cire d'abeille
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 2 Capsule | Not specified |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps to maintain women's health. Calcium intake, when combined with sufficient vitamin D, a healthy diet, and regular exercise, may reduce the risk of developing osteoporosis.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80010715
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2010. Photograph the packaging to check whether it has changed. Photograph the packaging